Company & Sponsor Intelligence

Loma Linda University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting0

Completed4

Countries1

Therapeutic footprint

anxietyautismdepressionpain_neuropathyparkinsonsstroke

Indexed studies

NCT02039271Effects of Music Listening on Pain and Patient Satisfaction Within First 48 Hours After Knee Replacment Surgery
pain_neuropathy · United StatesNA

NCT03446807Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
parkinsons · United StatesPHASE2

NCT03912896Taekwondo for Children With Autism Spectrum Disorder
autism · United StatesNA

NCT05382039Effects of Electrotherapy on Pain, Anxiety, Motion and Disability in Adults With Neck or Upper Body Pain.
anxiety · United StatesNA

NCT04283058Low Dose Ketamine Infusion for the Treatment of Resistant Depression
depression · United StatesWITHDRAWN

NCT02524015Novel Treatment For Pusher Syndrome Using Physical Therapy
stroke · NA

NCT02162979Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
parkinsons · United StatesPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →